Defining Clinically Important Outcomes for the Modified Harris Hip Score and Nonarthritic Hip Scope for Hip Arthroscopy to Treat Femoroacetabular Impingement at a Minimum 10-Year Follow-up
- PMID: 40516096
- DOI: 10.1177/03635465251344594
Defining Clinically Important Outcomes for the Modified Harris Hip Score and Nonarthritic Hip Scope for Hip Arthroscopy to Treat Femoroacetabular Impingement at a Minimum 10-Year Follow-up
Abstract
Background: The minimal clinically important difference (MCID), Patient Acceptable Symptom State (PASS), and substantial clinical benefit (SCB) are valuable clinical thresholds used to provide clinical relevance to patient outcome scores. In hip arthroscopy (HA) for femoroacetabular impingement (FAI) syndrome, these values have been defined for the short- and midterm postoperative period, but meaningful long-term thresholds have not been established.
Purpose: To define the MCID, PASS, and SCB for the modified Harris Hip Score (mHHS) and Nonarthritic Hip Score (NAHS) at a minimum follow-up of 10 years for patients who underwent HA for FAI syndrome.
Study design: Case series; Level of evidence, 4.
Methods: A retrospective cohort study including all patients who underwent primary HA for FAI with a single surgeon from February 2010 to December 2013 was performed. Patient outcomes were assessed with an anchor question, mHHS, and NAHS at baseline and at 1, 5, and 10 years of follow-up. MCID was calculated using the distribution-based method at all time points, using 0.5 standard deviations as the threshold. The anchor-based MCID, PASS, and SCB were calculated at 10 years using thresholds representing the optimal cutoff on a receiver operating characteristic curve. Correlations between baseline characteristics and achievement of the MCID, PASS, and SCB were assessed with binomial logistic regressions.
Results: The 154 patients included in the study had a mean age of 38.8 ± 13.0 years, a mean body mass index of 24.6 ± 3.9 kg/m2, and 63.6% were female. The distribution-based MCID values for 1-year, 5-year, and 10-year scores were 7.8, 8.3, and 9.5 for mHHS and 9.5, 10.4, and 10.2 for NAHS, respectively. The anchor-based MCID was 20.3 for mHHS and 24.4 for NAHS. The PASS was 81.9 for mHHS and 83.1 for NAHS. The SCB values were 34.0 and 41.9 for mHHS and NAHS, respectively. Increased body mass index was associated with decreased achievement of SCB for mHHS (P = .03) and NAHS (P = .04), as well as NAHS PASS (P = .01) and anchor-based MCID (P = .01).
Conclusion: The establishment of the MCID, SCB, and PASS for the NAHS and mHHS provides a valuable clinical context for improvements in outcome scores after HA. Anchor-based calculations were consistently higher than distribution-based calculations.
Keywords: FAIS; MCID; NAHS; PASS; SCB; arthroscopy; hip; mHHS.
Conflict of interest statement
One or more of the authors has declared the following potential conflict of interest or source of funding: T.Y. has received consulting fees and royalties from Arthrex. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.
Similar articles
-
What Are the Minimum Clinically Important Difference, Substantial Clinical Benefit, and Patient-Acceptable Symptom State Thresholds for the Modified Harris Hip Score and International Hip Outcome Tool 12 Among Patients Who Undergo Periacetabular Osteotomy?Clin Orthop Relat Res. 2025 Feb 12;483(7):1275-85. doi: 10.1097/CORR.0000000000003393. Online ahead of print. Clin Orthop Relat Res. 2025. PMID: 39937260
-
Surgical Hip Dislocation in the Era of Hip Arthroscopy Demonstrates High Survivorship and Improvements in Patient-reported Outcomes for Complex Femoroacetabular Impingement.Clin Orthop Relat Res. 2024 Sep 1;482(9):1671-1682. doi: 10.1097/CORR.0000000000003032. Epub 2024 Mar 21. Clin Orthop Relat Res. 2024. PMID: 38513108
-
Clinically Relevant Thresholds in Patient-Reported Outcomes: Do Patients' Expectations Evolve Over Long-term Follow-up?Am J Sports Med. 2025 Jul;53(9):2208-2216. doi: 10.1177/03635465251345823. Epub 2025 Jun 14. Am J Sports Med. 2025. PMID: 40516099
-
Minimal Clinically Important Difference, Substantial Clinical Benefit, and Patient Acceptable Symptom State Values After Hip Arthroscopy for Femoroacetabular Impingement Are Highly Dependent on Their Study Population and Calculation Methods: A Systematic Review.Arthroscopy. 2025 Jun;41(6):2105-2113. doi: 10.1016/j.arthro.2024.07.032. Epub 2024 Aug 13. Arthroscopy. 2025. PMID: 39147078
-
Patients Maintain Clinically Significant Outcomes at 5-Year Follow-Up After Hip Arthroscopy for Femoroacetabular Impingement Syndrome: A Systematic Review.Arthroscopy. 2023 Aug;39(8):1869-1881.e1. doi: 10.1016/j.arthro.2023.04.021. Epub 2023 May 18. Arthroscopy. 2023. PMID: 37207920
MeSH terms
LinkOut - more resources
Full Text Sources